MRI-defined microvascular obstruction in revascularized STEMI represents microvascular destruction and hemorrhage, identifying a potential target for adjunctive treatment.
MVO signals a target for adjunctive microvascular therapies in STEMI; extends RCT evidence to guide interventions beyond reperfusion.
The contrast-devoid core of revascularized STEMI contains extensive erythrocyte extravasation with microvascular damage. Attenuating the reperfusion-induced haemorrhage may be a novel target in future adjunctive STEMI treatment.
No takes yet. Share an insight, caveat, or question.
Robbers et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: